GlaxoSmithKline Stops Corporate Political Contributions

Pharmalot -- This is the latest move toward transparency in which drugmakers are disclosing more clinical trial data, payments to doctors, educational and charitable donations (Glaxo, for instance) and political contributions. Today, Glaxo says it is enacting a new global, voluntary policy to stop all of its corporate political contributions.

Back to news